ria

Umang Bhutada

@umang.6999
Maharashtra
3+ Years of experience
SEBI Registration INH000023001
I'm Umang Bhutada, based in Maharashtra. I hold a Master of Business Administration, the National Institute of Securities Markets Series XV certification, a National Stock Exchange technical analysis certification and a Lean Six Sigma Green Belt.
Trade Ideas
386
Opinions
845
Followers
118k

Expertise

Quantitative
Growth
Technical
Index Strategies
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
icon0%
Accuracy
Ask me Anything

Got a question? Ask me and I will answer it. Stay curious, stay hungry!

Posts

shared an insight ⚡️ 21 hours ago
HITACHI ENERGY: ORDER INFLOWS SOAR 86% RECORDS
POWERINDIA Record order book. Strong revenue growth. Is the momentum sustainable? Hitachi Energy India has announced its Q2 FY27 results. Key financial highlights: Revenue: ₹2,996.5 crore, up 63.5% YoY. Net profit: ₹318.5 crore, up 20.5% YoY. Operational EBITDA: ₹494.4 crore, up 69.5% YoY. Operational EBITDA margin: 16.5%. New orders: ₹4,120.8 crore, up 85.9% YoY. Order backlog: Record ₹33,335.4 crore. Why this matters: Strong order inflows from transmission, utilities and data centres provide significant revenue visibility. However, investors should also track how efficiently the company executes its growing order book. What to monitor next: Order execution and revenue conversion Operational EBITDA margin Data centre and transmission orders Export business growth Working capital and cash flows My analytical view: This is a strong operational quarter, particularly on orders and revenue. The key question is whether the company can sustain execution and convert its record backlog into profitable growth. Disclosure: State your actual holding or interest, if any, before publishing. SEBI RA Disclaimer: Umang Rajesh Bhutada is a SEBI-registered Research Analyst (INH000023001). This content is for educational and informational purposes only and is not investment advice. Securities investments are subject to market risks. Please consult a qualified financial professional before making investment decisions.
312
92
shared an insight ⚡️ 12th Nov
ALKEM LABS: REVENUE UP 14%, BUT PROFIT DECLINES 12%! 💊
ALKEM Growth in sales, but why is the bottom line under pressure? Alkem Laboratories has announced its Q2 FY27 consolidated results. Key financial highlights: Revenue: ₹4,552 crore, up 13.8% YoY. EBITDA: ₹1,025 crore, up 11.3% YoY. EBITDA margin: 22.5% versus 23% last year. Net profit: ₹675 crore, down 11.7% YoY. India sales: ₹3,027.5 crore, up 9.5%. International sales: ₹1,454 crore, up 22.3%. Why this matters: The company delivered healthy revenue growth, but net profit declined. Higher research and development expenses and the tax impact are important factors to examine. What to monitor next: India pharmaceutical sales US business growth and pricing pressure EBITDA margin movement R&D expenditure Biotech and MedTech business performance My analytical view: The quarter is mixed. Revenue and operating earnings improved, but shareholders need to understand why net profit declined despite higher sales. The international business and margin trajectory deserve attention. Disclosure: State your actual holding or interest, if any, before publishing. SEBI RA Disclaimer: Umang Rajesh Bhutada is a SEBI-registered Research Analyst (INH000023001). This content is for educational and informational purposes only and is not investment advice. Securities investments are subject to market risks. Please consult a qualified financial professional before making investment decisions.
526
76
shared an insight ⚡️ 12th Nov
PAGE INDUSTRIES: WILL MARGINS MAKE OR BREAK Q2?
PAGEIND Investors are watching demand, volumes and profitability. Page Industries is scheduled to announce its Q2 FY27 results today, November 12. The company is also considering a second interim dividend. Previous quarter snapshot (Q1 FY27, standalone): Revenue from operations: ₹1,420.45 crore. Net profit: ₹192.81 crore. Profit before tax: ₹258.57 crore. Q2 FY26 revenue: ₹1,290.86 crore. Q2 FY26 net profit: ₹194.76 crore. No verified Q2 FY27 analyst consensus was available in the sources reviewed. These are historical figures, not Q2 estimates. Why this matters: Page Industries' performance depends on consumer demand, product volumes, pricing and cost management. Its margin performance will be particularly important this quarter. What to monitor next: Revenue and volume growth EBITDA margin Raw material and operating costs Inventory and distribution performance Interim dividend announcement My analytical view: The company enters Q2 with a higher revenue base but a slightly lower Q1 profit compared with the previous year. Investors should look for an improvement in margins and volume-led growth. Disclosure: State your actual holding or interest, if any, before publishing. SEBI RA Disclaimer: Umang Rajesh Bhutada is a SEBI-registered Research Analyst (INH000023001). This content is for educational and informational purposes only and is not investment advice. Securities investments are subject to market risks. Please consult a qualified financial professional before making investment decisions.
630
82
    Read More Posts →

    FAQ's

    What are the top stock recommendations by Umang Bhutada?

    up
    Umang Bhutada regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include POWERINDIA, ALKEM and PAGEIND. Explore Umang Bhutada's complete list of posts and trade views on their StockGro profile.

    How can I follow Umang Bhutada's latest investment insights?

    up
    You can follow Umang Bhutada's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.

    What is Umang Bhutada's investment strategy?

    up
    Umang Bhutada follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.

    How long has Umang Bhutada been a SEBI-registered Research Analyst (RA)?

    up
    Umang Bhutada has been a SEBI-registered Research Analyst and have 3+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.

    Where can I see Umang Bhutada's past performance and stock picks?

    up
    You can check Umang Bhutada's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.

    How can I contact Umang Bhutada for stock market advice?

    up
    For stock market guidance from Umang Bhutada, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.

    What is Umang Bhutada's track record in predicting market movements?

    up
    Umang Bhutada has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.

    What is the SEBI Registration number for Umang Bhutada?

    up
    Umang Bhutada is a SEBI-registered Research Analyst with the SEBI Registration INH000023001. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
    Be Financially Free with StockGro